Clinical comparative analysis on schizophrenia treated with Aripiprazole and Colzapine
Liu Cai-xiu
Abstract
Liu Cai-xiu
Abstract
Objective: To explore the effect and safety of Aripiprazole and Clozapine in treating schizophrenia.Methods: 60 patients were randomly divided into Aripiprazole group and Clozapine group.The positive and negative symptoms were recorded before treatment and 1,2,4,6 and 8 weeks after treatment.The side-effect was evaluated by TESS.Results:No efficacy difference was found between the two groups.Patients in Aripiprazole group showed a good effect on recognition and negative symptoms,and the side-effect was also less than that of Clozapine group.Conclusion: Aripiprazole is safe,effective drug in treating schizophrenia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore the effect and safety of Aripiprazole and Clozapine in treating schizophrenia.Methods: 60 patients were randomly divided into Aripiprazole group and Clozapine group.The positive and negative symptoms were recorded before treatment and 1,2,4,6 and 8 weeks after treatment.The side-effect was evaluated by TESS.Results:No efficacy difference was found between the two groups.Patients in Aripiprazole group showed a good effect on recognition and negative symptoms,and the side-effect was also less than that of Clozapine group.Conclusion: Aripiprazole is safe,effective drug in treating schizophrenia.
Key concepts: Aripiprazole, Clozapine, Schizophrenia (object-oriented programming), Medicine, Side effect (computer science), Drug, Internal medicine, Psychiatry